Growth Metrics

Pharma-Bio Serv (PBSV) Short term Debt (2020 - 2021)

Pharma-Bio Serv (PBSV) has disclosed Short term Debt for 2 consecutive years, with $1.3 million as the latest value for Q2 2021.

  • For the quarter ending Q2 2021, Short term Debt rose 100.0% year-over-year to $1.3 million, compared with a TTM value of $1.3 million through Apr 2021, up 100.0%, and an annual FY2020 reading of $1.3 million, changed N/A over the prior year.
  • Short term Debt was $1.3 million for Q2 2021 at Pharma-Bio Serv, roughly flat from $1.3 million in the prior quarter.
  • Across five years, Short term Debt topped out at $1.3 million in Q4 2020 and bottomed at $643900.0 in Q2 2020.